ELEKTA REFINANCES 5 YEAR CREDIT FACILITY


ELEKTA REFINANCES 5 YEAR CREDIT FACILITY

PRESS RELEASE			
Stockholm, April 3, 2007

Today, Elekta AB (publ.) signed a five year extendable USD 175 million
Multi-Currency Revolving Credit Facility.  The coordinating Mandated Lead
Arranger was SEB Merchant Banking and the Mandated Lead Arrangers were Banc of
America Securities Ltd., Danske Bank and SEB Merchant Banking. 

The Facility will be used to refinance Elekta's existing USD 125 million
Multi-Currency Revolving Credit Facility dated 17th January 2005 with the same
lenders, and for general corporate purposes.

The new Facility offers better conditions in pricing as well as terms and
conditions and further strengthens Elekta's long term financing structure.


********

For further information, please contact:

Peter Ejemyr
Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000
e-mail: peter.ejemyr@elekta.com  

About Elekta

Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for improved
cancer care and management of brain disorders. All of Elekta's solutions employ
non-invasive or minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. 

Clinical solutions include among others Leksell Gamma Knife® for non-invasive
treatment of brain disorders and Elekta Synergy® for image guided radiation
therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April
2005, the Elekta Group is the world's largest supplier of oncology software. 

Elekta's systems and solutions are used at over 4,000 hospitals around the world
to treat cancer and manage clinical operations as well as to diagnose and treat
brain disorders, including tumors, vascular malformations and functional
disorders. 

With approx. 2,000 employees, Elekta's corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com and for more information about IMPAC Medical System please visit
www.impac.com.

Attachments

04032037.pdf